Do you want to read an article? Please log in or register.
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
Gynecologic Cancer
RECOMMENDED
Related content
Gynecologic Cancer
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
Lancet Oncol
Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C, Lindegaard JC, EMBRACE Collaborative Group.
doi: 10.1016/S1470-2045(20)30753-1
Gynecologic Cancer
Results of Image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study
Radiother Oncol
Petric P, Lindegaard JC, Sturdza A, Fokdal L, Kirchheiner K, Tan LT, Schmid MP, Haie-Meder C, Jürgenliemk-Schulz IM, van Limbergen E, Hoskin P, Gillham C, Tharavichitkul E, Mahantshetty U, Villafranca E, Tanderup K, Kirisits C, Pötter R
doi: 10.1016/j.radonc.2021.01.005
Gastrointestinal Cancer
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
Eur J Cancer.
Cascinu S, Poli D, Zaniboni A, Lonardi S, Labianca R, Sobrero A, Rosati G, Di Bartolomeo M, Scartozzi M, Zagonel V, Pella N, Banzi M, Torri V
doi: 10.1016/j.ejca.2019.01.020.
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
Genitourinary Cancer
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
doi: 10.1007/s00259-019-04568-1.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with non-small cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
Int J Cancer
Takada K, Shimokawa M, Takamori S, Shimamatsu S, Hirai F, Tagawa T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Inoue K, Yoneshima Y, Tanaka K, Okamoto I, Nakanishi Y, Mori M
doi: 10.1002/ijc.33557
Breast Cancer
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancer
Eur J Cancer.
Albanell J, Svedman C, Gligorov J, Holt SD, Bertelli G, Blohmer JU, Rouzier R, Lluch A, Eiermann W
doi: 10.1016/j.ejca.2016.06.027.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial
JAMA Oncol.
Salem A, Mistry H, Hatton M, Locke I, Monnet I, Blackhall F, Faivre-Finn C
doi: 10.1001/jamaoncol.
Gynecologic Cancer
Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study
Radiother Oncol.
Smet S, Pötter R, Haie-Meder C, Lindegaard JC, Schulz-Juergenliemk I, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van Limbergen E, Tanderup K, Kirchheiner K; EMBRACE Collaborative Group
doi: 10.1016/j.radonc.2018.03.009.